Terms: = Bone cancer AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919 AND Clinical Outcome
2 results:
1. Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity.
Prinzing B; Zebley CC; Petersen CT; Fan Y; Anido AA; Yi Z; Nguyen P; Houke H; Bell M; Haydar D; Brown C; Boi SK; Alli S; Crawford JC; Riberdy JM; Park JJ; Zhou S; Velasquez MP; DeRenzo C; Lazzarotto CR; Tsai SQ; Vogel P; Pruett-Miller SM; Langfitt DM; Gottschalk S; Youngblood B; Krenciute G
Sci Transl Med; 2021 Nov; 13(620):eabh0272. PubMed ID: 34788079
[TBL] [Abstract] [Full Text] [Related]
2. Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
Pellagatti A; Benner A; Mills KI; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Verma A; McDonald EJ; Killick S; Hellström-Lindberg E; Bullinger L; Wainscoat JS; Boultwood J
J Clin Oncol; 2013 Oct; 31(28):3557-64. PubMed ID: 24002510
[TBL] [Abstract] [Full Text] [Related]
